Stock Earnings
United Therapeutics Corp (UTHR) receives a Neutral rating from Goldman
United Therapeutics Corp’s recent filing unveils that its CHAIRPERSON & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $0.96
Menu
United Therapeutics Corp’s recent filing unveils that its CHAIRPERSON & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $0.96
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, United Therapeutics Corp revealed its CHAIRPERSON & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $0.93
In a filing, United Therapeutics Corp revealed its CHAIRPERSON & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $0.85